THBS2 and hepatocellular carcinoma: Analysis of data obtained in‐house and from a publicly available dataset (The Cancer Genome Atlas (TCGA), Liver Cancer (LIHC)) also showed THBS2 downregulation in HCC to be correlated with the worst recurrence‐free survival (Figure 5B).